Q3 results: Johnson & Johnson beats estimates on demand for cancer drug
The company said it expects some impact of inflation to ease next year but higher costs of inventory manufactured in 2022 could…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Johnson & Johnson
J&J gives notice to terminate Emergent manufacturing deal for COVID vaccine
The termination notice comes about a week after J&J had initially informed Emergent of its intent to end the pact based on the…
J&J and Momenta Pharma file patent infringement lawsuit against Natco, Mylan Pharma and others
Johnson & Johnson and Momenta Pharma lawsuit alleged infringement of two old patents associated with 20mg/ml and 40mg/ml…
J&J suspends COVID-19 vaccine sales forecast
The vaccine brought in $2.38 billion in sales last year
US FDA approves cancer therapy by Johnson & Johnson and Legend Biotech
The treatment, Carvykti/Cilta-cel, belongs to a class of drugs known as CAR-T therapies, or chimeric antigen receptor T-cell…
J&J reaches opioid settlement with holdout state New Mexico
Under the accord, J&J agreed to pay New Mexico its share of the nationwide settlement in 2022, rather than over several years,…
J&J says single dose protects against breakthrough COVID-19 for up to six months
The study, sponsored by the vaccine developer, was conducted between 1st January and 7th September last year, before the Omicron…
Vaccine makers could make Omicron-specific booster, says Fauci
The US government is working with Moderna, Pfizer and J&J on multiple contingency plans, infectious disease expert Anthony…
Schneider Electric launches programme to increase access to renewable energy for pharmaceutical…
The collaboration aims to accelerate the adoption of renewable energy and reduce greenhouse gas emissions within the…
FDA takes additional actions on use of booster dose for COVID-19 vaccines
The US health regulator talks about using single booster dose of the vaccines developed by Moderna, Johnson & Johnson and…